SCHEMBL22780923

SCHEMBL22780923

[N-]=[N+]=NCCC1=CCCN(OC(=O)c2ccccc2)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
CHRNA5 P30532 1/20 0.34
CHRNA7 P36544 1/20 0.34
KMT2A Q03164 7/20 0.34
MEN1 O00255 3/20 0.34
LMNA P02545 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
BLM P54132 2/20 0.33
PMP22 Q01453 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
MAPK1 P28482 2/20 0.33
TP53 P04637 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX12 P18054 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21361040 0.83 CHRNB2 (0.39) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL27312693 0.73 TSHR (0.42) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL10389764 0.69 KMT2A (0.42) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL21361041 0.68 GAA (0.37) CHRNB2CHRNA4
SCHEMBL27045573 0.68 F2 (0.47) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL1266020 0.68 F2 (0.47) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL26114506 0.65 TDP1 (0.59) KMT2ALMNAALDH1A1CYP1A2CYP2C9
SCHEMBL9772117 0.65 SMO (0.36) KMT2ALMNAALDH1A1MAPTPOLB
SCHEMBL2510973 0.64 KMT2A (0.50) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A
SCHEMBL25699197 0.64 F2 (0.42) CHRNB2CHRNA4CHRNA5CHRNA7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3129372-B1 AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C CANCER RESEARCH TECH LTD (GB) 2020-12-16 EP disclosed